Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared with 2-dose BNT162b2 vaccination in kidney transplant recipients

Kidney Int. 2022 Mar;101(3):639-642. doi: 10.1016/j.kint.2021.12.009. Epub 2021 Dec 23.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • BNT162 Vaccine*
  • COVID-19*
  • Humans
  • Kidney Transplantation*
  • SARS-CoV-2
  • Transplant Recipients

Substances

  • Antibodies, Viral
  • BNT162 Vaccine